← Eichor
Condition: Hiv 2 Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hiv 2 Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation
NA · 6 location(s) · Northwestern University · NCT06880224Accelerated ART Initiation for PWHIV Who Are Out of Care
Phase 4 · 4 location(s) · University of Missouri-Columbia · NCT06374758Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
NA · 3 location(s) · bioLytical Laboratories · NCT07563309A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
Phase 1/Phase 2 · 1 location(s) · ViiV Healthcare · NCT07275606Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Phase 1/Phase 2 · 8 location(s) · ViiV Healthcare · NCT05674656Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
Phase 2 · 6 location(s) · Mundipharma Research Limited · NCT05835479HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Phase 1 · 1 location(s) · Yale University · NCT06513819Trial of Ixazomib for Kaposi Sarcoma
Phase 2 · 11 location(s) · AIDS Malignancy Consortium · NCT04305691Boosting Olfactory and Sensory Training Study (BOOST)
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT07221123Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafe
Phase 4 · 1 location(s) · Instituto Mexicano del Seguro Social · NCT07678268Improving Coronary Vascular Health in Women
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06843902Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT05215704Appalachian Partnership to Reduce Disparities (Aim 2)
NA · 1 location(s) · Wake Forest University Health Sciences · NCT04378439Tools to Identify People At Risk or Already Infected with HIV and HCV
NA · 1 location(s) · Fundacion para la Investigacion Biomedica del Hospital Unive · NCT06528626Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
NA · 1 location(s) · Instituto Nacional de Saúde, Mozambique · NCT06326294Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
Phase N/A · 2 location(s) · Duke University · NCT05129345Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Tha
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05580458Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug
Phase 4 · 1 location(s) · José Antonio Mata Marín · NCT07138144Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-0
Phase 2 · 24 location(s) · Merck Sharp & Dohme LLC · NCT04375800A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · 55 location(s) · Merck Sharp & Dohme LLC · NCT07266831Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal o
NA · 5 location(s) · Centre Hospitalier Régional d'Orléans · NCT06834113Food as Medicine for HIV and Diabetes
NA · 1 location(s) · University of North Carolina, Chapel Hill · NCT05026723The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care
NA · 1 location(s) · Brigham and Women's Hospital · NCT06554223
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.